Medtechs Should Not Play Dodgeball With Sales Force Effectiveness
Executive Summary
Adoption of sales force effectiveness remains suboptimal across the US medtech industry, which means that companies are missing out on significant annual revenue uplift. But things are changing, and it’s no longer an issue to be delegated: SFE has risen all the way to CEO level.